Search - tctmd.com

Displaying 1 - 20 of 63

Sort: Relevancy | Date

News Conference News ESC 2025

HI-PRO: Oral Apixaban for 1 Year Protective, Safe in Provoked VTE Patients

Caitlin E. Cox

September 01, 2025

News Conference News ACC 2025

Low-Dose Apixaban Prevents Recurrent VTE in Cancer Beyond 6 Months: API-CAT

Caitlin E. Cox

March 29, 2025

News Daily News

New Data Reassure on Rivaroxaban’s Role in Frail PAD Patients

L.A. McKeown

August 19, 2024

News Daily News

DOAC Don’ts: New Review Clarifies When Not to Use Direct Oral Anticoagulants

Shelley Wood

January 17, 2024

Presentation TCT 2023

My Worst DVT of the Year

Presenter: Ari Mintz

October 26, 2023

Presentation TCT 2023

My Best DVT Case of the Year

Presenter: Matthew Finn

October 26, 2023

Presentation TCT 2023

My Worst PE Case of the Year

Presenter: Asma Khaliq

October 26, 2023

Presentation TCT 2023

My Best PE Case of the Year

Presenter: Tai Kobayashi

October 26, 2023

News Daily News

TCTMD’s Top 10 Most Popular Stories for September 2023

Shelley Wood

October 03, 2023

News Conference News ESC 2023

ONCO DVT Supports 12 Months of Preventive DOACs in Cancer Patients

L.A. McKeown

August 30, 2023

Presentation Fellows 2023

FLAME and clinical implications for high risk PE

Presenter: Jay Giri

May 12, 2023

Presentation Fellows 2023

Why intervene in intermediate risk patients

Presenter: Jun Li

May 12, 2023

Presentation Fellows 2023

A cardiologist’s perspective on the importance of treating VTE

Presenter: Sahil Parikh

May 12, 2023

Presentation Fellows 2023

The VTE landscape – where we are and where we’re going

Presenter: Thomas Tu

May 12, 2023

Presentation Fellows 2023

New Technology to Address VTE Thrombus Removal

Presenter: S. Jay Mathews

May 11, 2023

News Daily News

Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest

Michael O'Riordan

October 20, 2022

Presentation TCT 2022

Catheter-Based Management of Infectious Endocarditis

Presenter: Abdallah El Sabbagh

September 19, 2022

Presentation TCT 2022

R Sided Clot in Transit

Presenter: Matthew Finn

September 19, 2022

Presentation TCT 2022

Introduction to the PE/VTE landscape and critical unmet needs

Presenter: Shon Chakrabarti

September 19, 2022

Presentation TCT 2022

Case 3: Post-Partum May-Thurner Acute DVT

Presenter: Maya Serhal

September 18, 2022

Advertisement

HI-PRO: Oral Apixaban for 1 Year Protective, Safe in Provoked VTE Patients

Low-Dose Apixaban Prevents Recurrent VTE in Cancer Beyond 6 Months: API-CAT

New Data Reassure on Rivaroxaban’s Role in Frail PAD Patients

DOAC Don’ts: New Review Clarifies When Not to Use Direct Oral Anticoagulants

My Worst DVT of the Year

My Best DVT Case of the Year

My Worst PE Case of the Year

My Best PE Case of the Year

TCTMD’s Top 10 Most Popular Stories for September 2023

ONCO DVT Supports 12 Months of Preventive DOACs in Cancer Patients

FLAME and clinical implications for high risk PE

Why intervene in intermediate risk patients

A cardiologist’s perspective on the importance of treating VTE

The VTE landscape – where we are and where we’re going

New Technology to Address VTE Thrombus Removal

Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest

Catheter-Based Management of Infectious Endocarditis

R Sided Clot in Transit

Introduction to the PE/VTE landscape and critical unmet needs

Case 3: Post-Partum May-Thurner Acute DVT

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content